An Unveiled Cell Death Mechanism Exclusive to Human Cancer Cells †
Abstract
:Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Reference
- Cohen-Armon, M. Exclusive modifications of NuMA in malignant epithelial cells: A potential therapeutic mechanism. Drug. Dis. Today 2022, 27, 1205–1209. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cohen-Armon, M. An Unveiled Cell Death Mechanism Exclusive to Human Cancer Cells. Biol. Life Sci. Forum 2023, 21, 14. https://doi.org/10.3390/blsf2023021014
Cohen-Armon M. An Unveiled Cell Death Mechanism Exclusive to Human Cancer Cells. Biology and Life Sciences Forum. 2023; 21(1):14. https://doi.org/10.3390/blsf2023021014
Chicago/Turabian StyleCohen-Armon, Malka. 2023. "An Unveiled Cell Death Mechanism Exclusive to Human Cancer Cells" Biology and Life Sciences Forum 21, no. 1: 14. https://doi.org/10.3390/blsf2023021014
APA StyleCohen-Armon, M. (2023). An Unveiled Cell Death Mechanism Exclusive to Human Cancer Cells. Biology and Life Sciences Forum, 21(1), 14. https://doi.org/10.3390/blsf2023021014